Item 1. Financial Statements
Item
1. Financial Statements
Our
consolidated financial statements included in this Form 10-Q are as follows:
F-1
Consolidated Balance Sheets as of September 30, 2023 (unaudited) and December 31, 2022;
F-2
Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and 2022 (unaudited);
F-3
Consolidated Statement of Stockholders’ Equity (Deficit) for the three and nine months ended September 30, 2023 and 2022 (unaudited);
F-5
Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022 (unaudited); and
F-6
Notes to Consolidated Financial Statements.
These
consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States
of America for interim financial information and the SEC instructions to Form 10-Q. In the opinion of management, all adjustments considered
necessary for a fair presentation have been included. Operating results for the interim three and nine months ended September 30, 2023
are not necessarily indicative of the results that can be expected for the full year.
3
Resonate Blends, Inc.
Consolidated Balance Sheets
(Unaudited)
September 30, 2023
December 31, 2022
ASSETS
Current assets
Cash and cash equivalents
$ 588
$ 64,419
Inventory
100,883
160,492
Other receivable
120,000
150,000
Deposit on acquisition of Pegasus Specialty Vehicles LLC
720,000
-
Total current assets
941,471
374,911
Fixed assets, net
17,567
24,110
Investment
100
100
TOTAL ASSETS
$ 959,138
$ 399,121
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities
Accounts payable and accrued liabilities
$ 361,351
$ 319,618
Due to related parties
70,099
164,946
Convertible notes payable
1,652,609
988,800
Senior promissory note
575,000
-
Derivative liability
300,997
72,487
Total current liabilities
2,960,056
1,545,851
Total liabilities
2,960,056
1,545,851
Stockholders’ Deficit
Series B - Preferred stock, 66,667 shares authorized, $ 0.0001 par
value, 0 issued and outstanding
-
-
Series C - Preferred stock, 2,000,000 shares authorized, $ 0.0001
par value, 2,000,000 issued and outstanding
200
200
Series D Preferred stock 40,000 shares authorized, $ 0.0001 par
value 40,000 issued and outstanding
-
-
Preferred stock value
-
-
Common stock; $ 0.0001 par value; 200,000,000 shares authorized;
82,841,096 and 75,437,604 shares issued and outstanding
8,284
7,544
Common stock issuable
-
-
Stock subscription receivable
( 261,059 )
( 261,059 )
Additional paid-in capital
24,583,513
24,427,009
Accumulated deficit
( 26,331,856 )
( 25,320,424 )
Total stockholders’ deficit
( 2,000,918 )
( 1,146,730 )
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
$ 959,138
$ 399,121
The accompanying notes are an integral part of these consolidated financial statements.
F- 1
Resonate Blends, Inc.
Consolidated Statements of Operations
(Unaudited)
September 30, 2023
September 30, 2022
September 30, 2023
September 30, 2022
Three Months Ended
Nine Months Ended
September 30, 2023
September 30, 2022
September 30, 2023
September 30, 2022
REVENUES
$ -
$ 10,429
$ 16,468
$ 40,917
COST OF REVENUES
-
9,718
13,257
24,996
Gross profit
-
711
3,211
15,921
OPERATING EXPENSES
Advertising
135
94,978
13,572
330,255
General and administrative
22,785
44,179
114,220
150,682
Legal and professional
24,055
62,969
62,835
136,307
Officer compensation
-
16,750
5,000
341,000
Non cash management fees
-
-
-
206,462
Total operating expenses
46,975
218,876
195,627
1,164,706
OPERATING LOSS
( 46,975 )
( 218,165 )
( 192,416 )
( 1,148,785 )
OTHER INCOME (EXPENSES)
Interest expense
( 155,756 )
( 70,052 )
( 307,865 )
( 92,853 )
Gain (loss) on change in derivative liability
123,227
526,415
( 228,510 )
2,213,527
Amortization of issuance costs
( 143,633 )
-
( 277,608 )
( 31,795 )
Gain (loss) on settlement of notes payable
( 5,033 )
( 176,096 )
( 5,033 )
( 176,222 )
Total operating income (expense)
( 181,195 )
280,267
( 819,016 )
1,912,657
NET INCOME (LOSS)
$ ( 228,170 )
$ 62,102
$ ( 1,011,432 )
$ 763,872
INCOME (LOSS) PER SHARE- basic and diluted
$ ( 0.00 )
$ 0.00
$ ( 0.01 )
$ 0.01
WEIGHTED AVERAGE SHARES OUTSTANDING
81,748,762
75,412,604
77,912,142
75,412,604
The accompanying notes are an integral part of these consolidated financial statements.
F- 2
Resonate Blends, Inc.
Consolidated Statement of Stockholders’ Deficit
(Unaudited)
Shares
Amount
Shares
Amount
Shares
Amount
Capital
Issuable
Receivable
Deficit
Total
Preferred Stock
Preferred Stock
Additional
Common
Series A
Series C
Common Stock
Paid-in
Stock
Subscription
Accumulated
Shares
Amount
Shares
Amount
Shares
Amount
Capital
Issuable
Receivable
Deficit
Total
Balance, December 31, 2021
-
$ -
2,000,000
$ 200
45,046,637
$ 4,504
$ 21,867,416
$ -
$ -
$ ( 25,974,051 )
$ ( 4,101,931 )
Issuance of common stock in private placement
-
-
-
-
1,065,556
107
260,952
-
( 261,059 )
-
-
Issuance of common stock for debt conversions
-
-
-
-
780,000
78
131,447
-
-
-
131,525
Stock issuance for services
-
-
-
-
904,666
90
201,957
-
-
-
202,047
Net income
-
-
-
-
-
-
-
-
490,040
490,040
Balance, March 31, 2022
-
-
2,000,000
200
47,796,859
4,779
22,461,772
-
( 261,059 )
( 25,484,011 )
( 3,278,319 )
Stock issuance for services
-
-
-
-
50,000
5
4,500
-
-
-
4,505
Net income
-
-
-
-
-
-
-
-
-
211,730
211,730
Balance, June 30, 2022
-
-
2,000,000
200
47,846,859
4,784
22,466,272
-
( 261,059 )
( 25,272,281 )
( 3,062,084 )
Stock issuance for services
-
-
-
-
25,000
3
2,246
-
-
-
2,249
Stock issuance for debt conversion
-
-
-
-
21,969,316
2,197
1,973,944
-
-
-
1,976,141
Stock issuance in private placement
-
-
-
-
5,571,429
557
243,360
-
-
-
243,917
Net income
-
-
-
-
-
-
-
-
-
62,102
62,102
Balance, September 30, 2022
-
$ -
2,000,000
$ 200
75,412,604
$ 7,541
$ 24,685,822
$ -
$ ( 261,059 )
$ ( 25,210,179 )
$ ( 777,675 )
Balance
-
$ -
2,000,000
$ 200
75,412,604
$ 7,541
$ 24,685,822
$ -
$ ( 261,059 )
$ ( 25,210,179 )
$ ( 777,675 )
The accompanying notes are an integral part of these consolidated financial statements.
F- 3
Resonate Blends, Inc.
Consolidated Statement of Stockholders’ Deficit
(Unaudited)
Shares
Amount
Shares
Amount
Shares
Amount
Capital
Issuable
Receivable
Deficit
Total
Preferred Stock
Preferred Stock
Additional
Common
Series A
Series C
Common Stock
Paid-in
Stock
Subscription
Accumulated
Shares
Amount
Shares
Amount
Shares
Amount
Capital
Issuable
Receivable
Deficit
Total
Balance, December 31, 2022
-
$ -
2,000,000
$ 200
75,437,604
$ 7,544
$ 24,427,009
$ -
$ ( 261,059 )
$ ( 25,320,424 )
$ ( 1,146,730 )
Reclassification of convertible debt
-
-
-
-
-
-
( 247,142 )
-
-
-
( 247,142 )
Exercise of warrants
-
-
-
-
-
-
-
6,000
-
-
6,000
Net loss
-
-
-
-
-
-
-
-
-
( 380,952 )
( 380,952 )
Balance, March 31, 2023
-
-
2,000,000
200
75,437,604
7,544
24,179,867
6,000
( 261,059 )
( 25,701,376 )
( 1,768,824 )
Exercise of warrants
-
-
-
-
1,273,273
127
29,873
( 6,000 )
-
-
24,000
Stock issuance for services
-
-
-
-
250,000
25
2,278
-
-
-
2,303
Issuance of common stock for commitment fees
-
-
-
-
1,368,000
137
45,548
-
-
-
45,685
Net loss
-
-
-
-
-
-
-
-
-
( 402,310 )
( 402,310 )
Balance, June 30, 2023
-
-
2,000,000
200
78,328,877
7,833
24,257,566
-
( 261,059 )
( 26,103,686 )
( 2,099,146 )
Balance
-
-
2,000,000
200
78,328,877
7,833
24,257,566
-
( 261,059 )
( 26,103,686 )
( 2,099,146 )
Recognition of stock issued for services
-
-
-
-
-
-
3,592
-
-
-
3,592
Stock issuance for services
-
-
-
-
-
-
3,592
-
-
-
3,592
Issuance of common stock in private placement
-
-
-
-
137,500
14
9,986
-
-
-
10,000
Conversion of convertible debt
-
-
-
-
3,282,219
328
241,900
-
-
-
242,228
Issuance of common stock for commitment fees
-
-
-
-
1,092,500
109
70,469
-
-
-
70,578
Net loss
-
-
-
-
-
-
-
-
-
( 228,170 )
( 228,170 )
Net Income (loss)
-
-
-
-
-
-
-
-
-
( 228,170 )
( 228,170 )
Balance, September 30, 2023
-
$ -
2,000,000
$ 200
82,841,096
$ 8,284
$ 24,583,513
$ -
$ ( 261,059 )
$ ( 26,331,856 )
$ ( 2,000,918 )
Balance
-
$ -
2,000,000
$ 200
82,841,096
$ 8,284
$ 24,583,513
$ -
$ ( 261,059 )
$ ( 26,331,856 )
$ ( 2,000,918 )
The accompanying notes are an integral part of these consolidated financial statements.
F- 4
Resonate Blends, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
September 30, 2023
September 30, 2022
Nine
Months Ended
September 30, 2023
September 30, 2022
Cash Flows from Operating Activities
Net income (loss)
$ ( 1,011,432 )
$ 763,872
Adjustments to reconcile net income (loss) to net cash used in operations
Loss (gain) on derivative liability
228,510
( 2,213,527 )
Non cash interest expense
277,608
-
Gain on settlement of notes payable
-
-
Share professional fees/ compensation
122,158
206,462
Depreciation and amortization
6,543
6,513
Stock subscription receivable
-
( 261,059 )
Changes in operating assets and liabilities
Inventory
59,609
50,488
Advances to suppliers
-
( 8,762 )
Other receivables
30,000
( 126,811 )
Accounts payable and accrued expenses
376,820
107,970
Due to related party
-
( 2,000 )
Net cash provided by (used in) operating activities
89,816
( 1,476,854 )
Cash Flows from Investing Activities
Deposit on acquisition of Pegasus Specialty Vehicles LLC
( 720,000 )
-
Net cash provided by (used in) investing activities
( 720,000 )
-
Cash Flows from Financing Activities
Proceeds from issuance of convertible notes
760,000
1,388,800
Proceeds from subscription
-
349,981
Proceeds from private placement
10,000
-
Proceeds from warrant exercise
30,000
-
Repayment of related party advances
( 94,847 )
-
Repayment of convertible notes
( 138,800 )
-
Net cash provided by (used in) financing activities
566,353
1,738,781
Net increase (decrease) in cash
( 63,831 )
261,927
Cash, beginning of period
64,419
12,913
Cash, end of period
$ 588
$ 274,840
Supplemental cash flow disclosures
Cash paid for interest
$ -
$ -
Cash paid for taxes
$ -
$ -
Non-cash investing and financing activities
Conversion of debt for common stock
$ 242,228
$ 2,265,000
The accompanying notes are an integral part of these consolidated financial statements.
F- 5
RESONATE
BLENDS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023
(UNAUDITED)
NOTE
1 – ORGANIZATION AND BUSINESS OPERATIONS
The
Company
Resonate
Blends, Inc. (the “Company”) was incorporated on in October 1984 in the State of Georgia as Brock Control Systems. Founded
by Richard T. Brock, the Company was in the sales automation market and an early developer of enterprise customer management systems.
The Company went public at the end of March of 1993. In February of 1996, the Company changed its name to Brock International Inc., and
in March of 1998, the Company again changed our name to Firstwave Technologies, Inc.
In
2007, the Company deregistered its common stock in order to avoid the expenses of being a public company. The Company reported briefly
on the OTC Disclosure & News Service in 2008 but not for long. The Company again changed its name to FSTWV, Inc.
On
October 28, 2013, the Company held a shareholder meeting to reincorporate the company in the State of Nevada and concurrently change
its name to Textmunication Holdings, Inc. The Company also voted to approve a 1 for 5 reverse split of its outstanding common stock.
On
November 16, 2013, the Company entered into a Share Exchange Agreement (SEA) with Textmunication, Inc. a California corporation, whereby
the sole shareholder of the Company received 65,640,207 new shares of common stock of the Company in exchange for 100 % of the Textmunication’s
issued and outstanding shares. Textmunication is an online mobile marketing platform service.
On
October 25, 2019, the Company entered into a Membership Interest Purchase Agreement (the “Resonate Purchase Agreement”) with
Resonate Blends, LLC, a California limited liability company (“Resonate”), and the members of Resonate. As a result of the
transaction, Resonate became a wholly owned subsidiary of the Company. In accordance with the terms of the Purchase Agreement, at the
closing an aggregate of 5 % of the Company’s outstanding shares of common stock for a total of 665,072 shares were issued to the
holders of Resonate in exchange for their membership interests of Resonate. These shares have anti-dilution protection. We have also
agreed as part of the purchase price to issue: (ii) such number of shares of Series E Preferred Stock that will convert into 5% of the
outstanding shares of common stock in the Company on a fully-diluted basis upon an annualized revenue run rate of Ten Million Dollars
($10,000,000.00) for any three (3) consecutive month trailing period; and (iii) such number of shares of Series E Preferred Stock that
will convert into 5% of the outstanding shares of common stock in the Company on a fully-diluted basis upon the occurrence of the Company’s
public market value reaching One Hundred Million US Dollars ($100,000,000). The shares in (ii) and (iii) shall have anti-dilution protections,
except that this provision only applies for 2.5% of the outstanding shares acquired under each subsection.
Also,
on October 25, 2019, the Company entered into a Membership Interest Purchase Agreement (the “Entourage Labs Purchase Agreement”)
with Entourage Labs, LLC, a California limited liability company (“Entourage Labs”), and the members of Entourage Labs. As
a result of the transaction, Entourage Labs became a wholly owned subsidiary of the Company. In accordance with the terms of the Purchase
Agreement, at the closing an aggregate of 5 % of the Company’s outstanding shares of common stock for a total of 665,072 shares
were issued to the holders of Entourage Labs in exchange for their membership interests of Entourage Labs. These shares have anti-dilution
protection. We have also agreed as part of the purchase price to issue: (ii) such number of shares of Series E Preferred Stock that will
convert into 5% of the outstanding shares of common stock in the Company on a fully-diluted basis upon an annualized revenue run rate
of Ten Million Dollars ($10,000,000.00) for any three (3) consecutive month trailing period; and (iii) such number of shares of Series
E Preferred Stock that will convert into 5% of the outstanding shares of common stock in the Company on a fully-diluted basis upon the
occurrence of the Company’s public market value reaching One Hundred Million US Dollars ($100,000,000). The shares in (ii) and
(iii) shall have anti-dilution protections, except that this provision only applies for 2.5% of the outstanding shares acquired under
each subsection.
F- 6
In
addition, the Company entered into an Agreement of Conveyance, Transfer and Assignment of Assets and Assumption of Obligations (the “Conveyance
Agreement”) with Mark S. Johnson and the Company’s 49 % owned subsidiary, Aspire Consulting Group, LLC, a Virginia limited
liability company. Pursuant to the Conveyance Agreement, the Company transferred all assets and business operations associated with its
IT consulting solutions, including all of the capital stock of Aspire Consulting, to Mr. Johnson. In exchange, Mr. Johnson agreed to
cancel 20,000 shares of common stock in the Company and to assume and cancel all liabilities relating to the Company’s former business.
Finally,
the Company entered into Employment Agreements with the following persons: (i) Geoffrey Selzer as Chief Executive Officer (CEO) of the
Company with an annual salary of $ 180,000 ; and (ii) Pamela Kerwin as Chief Operating Officer (COO) of the Company with an annual salary
of $ 120,000 . Both are eligible for salary increases upon milestone achievements and other benefits. The Employment Agreement for the
CEO has a term of 2 years and can’t be terminated without cause. Severance of six (6) weeks is available for termination of the
COO without cause before one-year of service and eight (8) weeks after one-year of service. During the quarter ended March 31, 2023,
these employment agreements were suspended.
On
December 16, 2019 the Company filed Articles of Merger with the Secretary of State of Nevada in order to effectuate a merger with its
wholly owned subsidiary; Resonate Blends, Inc. Shareholder approval was not required under Section 92A.180 of the Nevada Revised Statutes.
As part of the merger, the Company’s board of directors authorized a change in our name to “Resonate Blends, Inc.”
and the Company’s Articles of Incorporation have been amended to reflect this name change.
In
connection with the name change, the Company’s symbol was changed to “KOAN” that more resembles the Company’s
new business focus.
On
June 20, 2023, the Company entered into an Agreement and Plan of Merger with Pegasus Specialty Vehicles, LLC, an Ohio limited liability
company, and Pegasus Specialty Holdings LLC, an Ohio limited liability company and wholly-owned subsidiary of the Company.
Basis
of Presentation
The
accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally
accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with
the audited financial statements and notes thereto contained in the Company’s most recent Annual Financial Statements filed with
the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair
presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results
of operations for the interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial
statements which would substantially duplicate the disclosures contained in the audited financial statements for the most recent fiscal
period, as reported in the Form 10-K, have been omitted.
Reclassifications
Certain
reclassifications have been made to the September 30, 2022 classifications to make them comparable to September 30, 2023.
Going
concern
These
consolidated financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going
concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.
As of September 30, 2023, the Company has an accumulated deficit of $ 26,331,856 . The company’s ability to continue as a going concern
is contingent upon the successful completion of additional financing arrangements and its ability to achieve and maintain profitable
operations. While the Company is expanding its best efforts to achieve the above plans, there is no assurance that any such activity
will generate funds that will be available for operations. These conditions raise substantial doubt about the Company’s ability
to continue as a going concern for a period of one year from the issuance of these financial statements. These consolidated financial
statements do not include any adjustments that might arise from this uncertainty.
F- 7
N OTE
2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Use
of Estimates
The
preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ
from those estimates.
Consolidation
These
consolidated financial statements have been prepared in accordance with U.S. GAAP and include the accounts of the Company and its wholly
owned subsidiaries. All intercompany transactions and balances have been eliminated.
Cash
The
Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents.
The
Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution.
The balance at times may exceed federally insured limits.
Accounts
receivable and allowance for doubtful accounts
Accounts
receivables are stated at the amount management expects to collect. The Company generally does not require collateral to support customer
receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical
collection information and existing economic conditions. As of September 30, 2023 and December 31, 2022, there’s no allowance for
doubtful accounts and bad debts.
Revenue
Recognition
The
Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that the
Company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the Company expects to be entitled to receive in exchange for those goods or services. To determine revenue recognition for
arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:
●
Identification
of the contract, or contracts, with a customer
●
Identification
of the performance obligations in the contract
●
Determination
of the transaction price
●
Allocation
of the transaction price to the performance obligations in the contract
●
Recognition
of the revenue when, or as, performance obligations are satisfied
Revenue
is generally recognized upon purchase of products by customers.
Fair
Value of Financial Instruments
The
carrying amounts reflected in the balance sheets for cash, accounts payable and accrued expenses approximate the respective fair values
due to the short maturities of these items.
As
required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value
hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in
active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly;
and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
F- 8
The
three levels of the fair value hierarchy are described below:
Level
1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
Level
2: Quoted prices in markets that are not active, or inputs that is observable, either directly or indirectly, for substantially the full
term of the asset or liability;
Level
3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported
by little or no market activity).
Financial
assets and liabilities measured at fair value on a recurring basis are summarized below for the quarter ended September 30, 2023 and
year ended December 31, 2022.
SUMMARY
OF ASSETS AND LIABILITIES MEASURED AT VALUE ON RECURRING BASIS
As of September 30, 2023
Level 1
Level 2
Level 3
Total
Liabilities
Derivative Liabilities
-
-
$ 300,997
$ 300,997
As of December 31, 2022
Level 1
Level 2
Level 3
Total
Liabilities
Derivative Liabilities
-
-
$ 72,487
$ 72,487
Inventory
Inventory
is stated at the lower of cost or net realizable value. Cost is determined on a first in, first out basis.. Management compares the cost
of inventory with the net realizable value and, if applicable, an allowance is made for writing down the inventory to its net realizable
value, if lower than cost, inventory is reviewed for potential write-down for estimated obsolescence or unmarketable inventory based
upon forecasts for future demand and market conditions. Generally, the Company only keeps inventory on hand for sales made and in which
a deposit has been received.
Net
income (loss) per Common Share
Basic
net income (loss) per share is computed by dividing the net loss attributable to the common stockholders by the weighted average number
of shares of common stock outstanding during the period. Fully diluted loss per share is computed similar to basic loss per share except
that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential
common shares had been issued and if the additional common shares were dilutive.
Property
and equipment
Property
and equipment are stated at cost, less accumulated depreciation provided on the straight-line method over the estimated useful lives
of the assets, which range from three to seven years . Expenditures for renewals or betterments are capitalized, and repairs and maintenance
are charged to expense as incurred the cost and accumulated depreciation of assets sold or otherwise disposed of are removed from the
accounts, and any gain or loss thereon is reflected in operations. Company policies capitalize property and equipment for cost over $ 1,000 ,
asset acquired under $ 1,000 are charge to operations.
Income
Taxes
Income
taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities
are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using
the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available
evidence, are not expected to be realized. Because the Company has no net income, the tax benefit of the accumulated net loss has been
fully offset by an equal valuation allowance.
F- 9
Stock-Based
Compensation
The
Company accounts for employee stock-based compensation in accordance with the guidance of FASB ASC Topic 718, Compensation – Stock
Compensation which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the
financial statements based on their fair values. The fair value of the equity instrument is charged directly to compensation expense
and credited to additional paid-in capital over the period during which services are rendered.
The
Company follows ASC Topic 505-50, formerly EITF 96-18, “Accounting for Equity Instruments that are Issued to Other than Employees
for Acquiring, or in Conjunction with Selling Goods and Services,” for stock options and warrants issued to consultants and other
non-employees. In accordance with ASC Topic 505-50, these stock options and warrants issued as compensation for services provided to
the Company are accounted for based upon the fair value of the services provided or the estimated fair market value of the option or
warrant, whichever can be more clearly determined. The fair value of the equity instrument is charged directly to compensation expense
and additional paid-in capital over the period during which services are rendered.
NOTE
3 – RELATED PARTY TRANSACTIONS
Management
has periodically advanced funds to the Company for operating expenses. At September 30, 2023 and December 31, 2022, amounts due related
parties were $ 70,099 and $ 164,946 , respectively. These advances are non-interest bearing and payable upon demand.
NOTE
4 - CONVERTIBLE NOTE PAYABLE
Convertible
notes payable consists of the following as of September 30, 2023 and December 31, 2022:
SCHEDULE
OF CONVERTIBLE NOTES PAYABLE
September 30, 2023
December 31, 2022
Convertible notes face value
$ 1,660,000
$ 988,800
Less: Discounts
( 7,391 )
-
Less: Debt issuance cost
-
-
Net convertible notes
$ 1,652,609
$ 988,800
At
September 30, 2023 and December 31, 2022, $ 200,000 of the convertible notes was an 8 % Unsecured Convertible Promissory Note from an investor
issued March 5, 2021. The note has an automatic conversion into equity on the maturity date, which was July 3, 2022 , or if a Qualified
Financing (QF) of $ 5,000,000 is achieved, whichever occurs first. The maturity date pricing is $0.10. A QF converts into equity at the
lesser of $1.00 or 75% of the average selling price of the aggregate offering. On July 10, 2023, the note was converted to 3,282,219
shares of common stock.
During
the year ended December 31, 2022, the Company entered into Securities Purchase Agreements with five accredited investors, pursuant to
which we issued and sold to the investors convertible promissory notes with a total principal amount of $ 715,000 . We received $ 650,000
from the Notes after applying the original issue discount to the Notes. The Securities Purchase Agreements also included 812,500 warrants
with a 5 year life and exercise price of $ 0.40 and 650,000 commitment shares. These notes have a Fixed Conversion Price or, at the option
of the Holder in the event that the Borrower fails to complete a Qualified Offering before the five (5) month anniversary of the Issue
Date, the Registration Conversion Price . The “Fixed Conversion Price” shall mean $ 0.15 per share. The “Registration
Conversion Price” shall mean 75% multiplied by the Market Price (representing a discount rate of 25%). “Market Price”
means the volume weighted average of the Common Stock during the twenty (20) Trading Day period ending on the latest complete Trading
Day prior to the Conversion Date. The Company is currently working with each of the accredited investor on payoff options.
On
June 27, 2022, we issued and sold to an accredited investor a convertible promissory note the principal amount of $ 138,800 under a Securities
Purchase Agreement of the same date. We received $ 128,500 from the Note after applying the original issue discount to the Note. During
the nine months ended September 30, 2023, the Company repaid the entire note.
F- 10
On
September 8, 2022, we issued and sold a senior secured convertible promissory note to AJB Capital Investments LLC (“AJB”)
for a principal amount of $ 600,000 , together with guaranteed interest of 12 % per year calendar from the date hereof. All Principal and
Interest owing hereunder, along with any and all other amounts, shall be due and owing on the Maturity Date March 8, 2023 . We received
$ 540,000 from the Note after applying the original issue discount to the Note. The note is convertible at a Variable Conversion Price
shall equal the volume weighted average trading price (i) during the previous twenty (20) Trading Day period ending on the date of issuance
of this Note, or (ii) during the previous twenty (20) Trading Day period ending on the Conversion Date.
The
Maturity Date may be extended at the sole discretion of the Borrower up to six (6) months following the date of the original Maturity
Date hereunder. In the event that the Maturity Date is extended, the interest rate shall equal fifteen percent (15%) per annum for any
period following the original Maturity Date, payable monthly.
The
maturity date for repayment of the Notes is nine months from issuance and the Notes bear interest at 10 % per annum. On September 29,
2023, we entered into an amendment with AJB extending the maturity date of the Note through December 28, 2023 . In exchange for this amendment,
we issued AJB 3,000,000 shares (“extension shares”) of common stock. We can redeem certain shares if all principal and interest
is repaid in full prior to the new maturity date.
The
Securities Purchase Agreement contain a most favored nation provision that allows the Investor to claim any lower price from any future
securities six months after this closing and a blocker on issuing variable rate investments.
In
connection with the investment, the Company issued Commitment Shares to the Investors in the amount of 5,571,429 shares collectively
prior to the issuance of the 3,000,000 extension shares on September 29, 2023.
During
the nine months ended September 30, 2023, the Company issued 3 convertible promissory notes totaling $ 345,000 ,
net of debt issuance costs of $ 20,000 .
These notes are convertible into common stock into the next funding round expected to be priced at $ .08
per share issued in a Series Preferred with a 4 %
coupon payable until the Preferred is converted into common stock. A
2 -year cash Warrant with 50 %
coverage priced at $ .25
is also available as part of this conversion. A total of 812,500
commitment shares and
250,000 warrants issued. This Note has a personal guarantee for the full principal amount to Resonate Blends, Inc. by Darshan
Vyas, Principal of Pegasus. Resonate Blends, Inc. in return will guarantee the Lender.
As
of September 30, 2023 and December 31, 2022, accrued interest payable on notes payable was $ 252,091 and $ 265,480 respectively.
The
Company accounts for the fair value of the conversion features of its convertible debt in accordance with ASC Topic No. 815-15 “Derivatives
and Hedging; Embedded Derivatives” (“Topic No. 815-15”). Topic No. 815-15 requires the Company to bifurcate and separately
account for the conversion features as an embedded derivative contained in the Company’s convertible debt. The Company is required
to carry the embedded derivative on its balance sheet at fair value and account for’ any unrealized change in fair value as a component
of results of operations. The Company values the embedded derivatives using the Black-Scholes pricing model.
NOTE
5 – DERIVATIVE LIABILITIES
Certain
of the above convertible notes contained an embedded conversion option with a conversion price that could result in issuing an undeterminable
amount of future common stock to settle the host contract. Accordingly, the embedded conversion option is required to be bifurcated from
the host instrument (convertible note) and treated as a liability, which is calculated at fair value, and marked to market at each reporting
period.
The
Company used the Black-Scholes pricing model to estimate the fair value of its embedded conversion option and warrant liabilities on
both the commitment date and the remeasurement date with the following inputs:
SCHEDULE
OF DERIVATIVE LIABILITIES
September 30, 2023
December 31, 2022
Exercise price
$ 0.041 - $ 0.053
$ 0.030
Expected volatility
470 %
220 %
Risk-free interest rate
4.64 %
1.45 %
Expected term (in years)
1.00
.1
Expected dividend rate
0 %
0 %
F- 11
NOTE
6 – SENIOR PROMISSORY NOTE
On
June 20, 2023, the Company signed a Securities Purchase Agreement (“SPA”) with an accredited investor, pursuant to which
the Company issued and sold to the accredited investor a 15 % original issue discount Senior Promissory Note (non-convertible), dated
June 20, 2023, in the principal amount of $ 575,000 . The Senior Promissory Note is secured by all of the Company’s assets under
a separate security agreement between the accredited investor and the Company.
The
Company received $ 435,000 from the Senior Promissory Note after applying the original issue discount and commissions and fees. The proceeds
were utilized as a deposit on the Company’s acquisition of Pegasus Specialty Vehicles, LLC (See Note 7).
The
maturity date for repayment of the Senior Promissory Note is September 20, 2023 and bears interest at 15 % per annum starting 60 days
after issuance and interest payable in cash monthly thereafter. The Company may prepay the Senior Promissory Note at any time, but is
required to pay a premium of 104 % of the principal amount if repaid after 60 days.
As
additional consideration, the Company issued 1,318,000 shares of its common stock as commitment shares. The Company was required to issue
an additional 330,000 commitment shares due to the Senior Promissory Note not being prepaid at 60 days as required in the SPA. The Company
is currently working with investor to address the entire Note payoff.
In
the agreements, the Company agreed to certain restrictive covenants, including a restriction on borrowing and a most favored nation clause
in favor of the accredited investor for any future offerings not specifically exempted.
On
June 20, 2023, the Company and Pegasus Specialty Vehicles, LLC entered into a Loan and Security Agreement whereby the Company lent to
Pegasus the principal amount of $ 575,000 secured by all of the Pegasus’ assets, but subordinate to the security interest of accredited
investor and another lender of Pegasus.
NOTE
7 – AGREEMENT AND PLAN OF MERGER WITH PEGASUS SPECIALTY VEHICLES, LLC
On
June 20, 2023, the Company entered into an Agreement and Plan of Merger with Pegasus Specialty Vehicles, LLC, an Ohio limited liability
company (“Pegasus”), and Pegasus Specialty Holdings LLC, an Ohio limited liability company and wholly-owned subsidiary of
the Company (“Pegasus Sub”).
The
Merger Agreement provides that at the closing, subject to terms and conditions, Pegasus Sub will merge with and into Pegasus, with Pegasus
surviving as a wholly-owned subsidiary of the Company. At Closing of the Merger, the issued and outstanding common shares of Pegasus
will automatically be converted into the right to receive an aggregate of 623,500 shares of Series AA Preferred Stock of the Company.
The
Company, Pegasus, and Pegasus Sub have each made various representations and warranties and agreed to certain covenants in the Merger
Agreement, including a covenant by the Company that it would raise $ 3,000,000 less costs in new financing at Closing, with $ 435,000 loaned
pre-Closing to Pegasus under a secured promissory note with a face value of $ 575,000 . Pegasus granted a security interest to the Company
in all of Pegasus’ assets on the $ 575,000 loan, subordinate to other security interests as to the same collateral. The Company
received $ 500,000 from the Note after applying the Original Issue Discount (OID), $ 30,000 of which was used to pay commission to a broker
as placement agent, $ 30,000 was paid to the lender for its legal fees and $ 5,000 for a due diligence fee paid to the lender. The balance
was tendered to the Company to lend to Pegasus under a Loan and Security Agreement as described below.
Consummation
of the Merger is subject to the satisfaction or, if permitted by applicable law, waiver, by the Company, Pegasus, or both of various
conditions. For Pegasus, these conditions include, without limitation, (i) an agreeable plan to spin out the existing Company cannabis
assets and operations, (ii) an agreeable plan to transfer the outstanding shares of Series C Preferred Stock of the Company to Brian
Barrington simultaneously to the date of the aforementioned spin-out; (iii) an agreeable plan to retire the Series E Designation; (iv)
financing by the Company of $3,000,000 less costs; (v) the filing of the Certificate of Designation for the Series AA Preferred Stock
with the Secretary of State of Nevada; and (vi) certain other customary conditions. For the Company, these conditions include, without
limitation, (i) a secured promissory note issued by Pegasus to the Company in the amount of $500,000 with the collateral being a UCC
lien subordinate to other lenders; (ii) the payback by the Company of certain advances contributed by corporate officers and others in
the Company in an amount not to exceed $140,000; (iii) resolutions of the equity holders of Pegasus approving the Merger Agreement and
the transactions contemplated; and (iv) certain other customary conditions.
F- 12
The
Merger Agreement contains certain termination rights including the right of the parties to mutually agree upon termination, and by each
of the Company and Pegasus unilaterally if the other party has committed a violation of the covenants, representations and warranties
in the Merger Agreement.
The
Merger Agreement, the Merger, and the transactions contemplated thereby were unanimously approved by the board of directors of Pegasus,
and unanimously approved by the board of directors of the Company.
The
Closing of the Merger is expected to occur as soon as practicable after the satisfaction or waiver of all the conditions to Closing in
the Merger Agreement, which is currently expected to be in the 4th quarter of calendar year 2023.
NOTE
8 – COMMITMENTS AND CONTINGENCIES
Office
Lease
On
October 16, 2019, the Company signed a lease agreement that expires on thirty days’ notice. Rent expense was approximately $ 8,406
and $ 5,796 for the nine months ended September 30, 2023 and 2022, respectively.
Executive
Employment Agreement
On
October 25, 2019 the Company entered into Employment Agreements with the following persons: (i) Geoffrey Selzer as Chief Executive Officer
(CEO) of the Company with an annual salary of $ 180,000 ; (ii) Pamela Kerwin as Chief Operating Officer (COO) of the Company with an annual
salary of $ 120,000 ; (iii) David Thielen as Chief Investment Officer (CIO) of the Company with an annual salary of $ 120,000 . All are eligible
for salary increases upon milestone achievements and other benefits. The Employment Agreement for the CEO has a term of 2 years and can’t
be terminated without cause. Severance of six (6) weeks is available for termination of the COO and CIO without cause before one-year
of service and eight (8) weeks after one-year of service. These agreements were suspended during the three months ended March 31, 2023.
NOTE
9 – STOCKHOLDERS’ EQUITY
During
the nine months ended September 30, 2023, the Company issued the following shares of common stock:
●
The
Company issued 1,273,273 shares of common stock for the exercise of a warrant for proceeds of $ 30,000 ;
●
The
Company issued 250,000 shares of common stock under a consulting agreement with a 1 year term. The shares were valued at $ 14,250 ,
the fair value at the issuance date. Of this amount, $ 5,895 was recognized during the nine months ended September 30, 2023, with
the remaining $ 8,355 unrecognized.
●
The
Company issued a total of 2,460,500 shares of common stock as commitment fees under borrowing agreements. The Company recognized
$ 116,263 in expenses, the fair value of the common stock on the issuance dates.
●
The
Company issued 137,500 shares of common stock for $ 10,000 in a private placement.
●
The
Company issued a total of 3,282,219 shares of common stock as to convert a convertible note of $ 200,000 and accrued interest of $ 42,228 .
During
the nine months ended September 30, 2022, the Company issued the following shares of common stock:
●
The
Company issued 979,666 shares of common stock for services for $ 208,801 .
●
The
Company issued 6,636,985 shares of common stock for $ 243,917 in private placements.
●
The
Company issued a total of 22,749,316 shares of common stock as to convert convertible notes and accrued interest of $ 2,107,666 .
NOTE
10 – SUBSEQUENT EVENTS
On
October 13, 2023, we issued a Promissory Note to an accredited investor in the principal amount of $ 55,000 . We received $ 50,000 from
the note after applying the original issue discount of $ 5,000 in the transaction.
All
principal on the note is convertible at the investors’ option into our common stock in the next funding round which, if it occurs,
is expected to be priced at approximately $ .08 per share issued in a preferred stock.
We
were required to issue a total of 112,500 shares of our common stock in connection with the notes as commitment shares.
On
October 26, 2023, we issued a three-month Promissory Note to an accredited investor in the principal amount of $ 57,500 .
We received $ 45,000
from the note after paying the placement agent a fee of $ 5,000
and the original issue discount of $ 7,500
in the transaction.
We
were required to issue a total of 250,000 shares of our common stock in connection with the notes as commitment shares.
On
November 13, 2023, we issued a Promissory Note to an accredited Noteholder for $ 80,000 with a nine (9) month maturity date. The Note
carries twelve ( 12 % ) interest rate per annum. After the allowances for the $ 3,500 in legal fees and a $ 1,500 due diligence fee, the Company
received $ 75,000 . The Company has the right to prepay the Note prior to 180 days with a set prepayment fee.
If
the Note isn’t paid in full at Day 180, the Noteholder has the right to convert the Note at a 37% discount with the conversion
price determined on the basis of the lowest closing bid price for the Common Stock during the prior ten (10) trading day period .
F- 13
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.